Literature DB >> 10366917

Poor outcome of the PCA and Harris-Galante hip prostheses. Randomized study of 171 arthroplasties with 9-year follow-up.

J Thanner1, J Kärrholm, H Malchau, P Herberts.   

Abstract

155 patients (171 hips) with a mean age of 50 years (24-64) were randomized to uncemented PCA (84 hips) or Harris-Galante type I (87 hips) total hip arthroplasty. Clinical and radiographic evaluations were done regularly. The improvements in the Harris hip and pain scores did not differ. Osteolysis developed in 5 PCA and 17 Harris-Galante hips. 13 hips in the PCA and 16 in the Harris-Galante (HG) group were revised because of mechanical failures and 1 hip (HG) because of infection after a mean follow-up of 9 years. Decreased 10-year survival rate, based on revision as end-point, was noted for the PCA (85%), compared with the Harris-Galante cup (99%). The corresponding survival rate of the PCA stem (96%) was higher than that observed for the Harris-Galante design (86%). When radiographic failures were included, the survival rates of the 4 different components dropped to between 73% and 94%. These findings indicate that further revisions will be necessary and continuous radiographic follow-up is indicated to enable revision before severe bone destruction has occurred. Although the PCA and the Harris-Galante designs differed as regards the survival of the individual components, the overall clinical and radiographic survival rates of these cementless total hip arthroplasties were poor.

Entities:  

Mesh:

Year:  1999        PMID: 10366917     DOI: 10.3109/17453679909011255

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  13 in total

1.  Porous titanium construct cup compared to porous coated titanium cup in total hip arthroplasty. A randomised controlled trial.

Authors:  Mats Salemyr; Olle Muren; Thomas Eisler; Henrik Bodén; Ghazi Chammout; André Stark; Olof Sköldenberg
Journal:  Int Orthop       Date:  2014-10-22       Impact factor: 3.075

2.  Long-term results of uncemented acetabular cups with an ACS polyethylene liner. a 14-16-year follow-up study.

Authors:  E Garcia-Rey; E Garcia-Cimbrelo
Journal:  Int Orthop       Date:  2006-05-31       Impact factor: 3.075

3.  Vitamin-E diffused highly cross-linked polyethylene liner compared to standard liners in total hip arthroplasty. A randomized, controlled trial.

Authors:  Mats Salemyr; Olle Muren; Torbjörn Ahl; Henrik Bodén; Ghazi Chammout; André Stark; Olof Sköldenberg
Journal:  Int Orthop       Date:  2015-01-29       Impact factor: 3.075

4.  Method of fixation does not influence the overall risk of rerevision in first-time cup revisions.

Authors:  Maziar Mohaddes; Göran Garellick; Johan Kärrholm
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

5.  Cementless total hip arthroplasty for primary osteoarthritis in patients aged 55 years and older.

Authors:  Keijo T Mäkelä; Antti Eskelinen; Pekka Paavolainen; Pekka Pulkkinen; Ville Remes
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

6.  Uncemented and cemented primary total hip arthroplasty in the Swedish Hip Arthroplasty Register.

Authors:  Nils P Hailer; Göran Garellick; Johan Kärrholm
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

7.  Clinical and radiological results of hydroxyapatite-coated acetabular cups.

Authors:  J Blacha; J Gagała
Journal:  Int Orthop       Date:  2004-08-14       Impact factor: 3.075

8.  Fatigue in cemented acetabular replacements.

Authors:  J Tong; N P Zant; J-Y Wang; P Heaton-Adegbile; J G Hussell
Journal:  Int J Fatigue       Date:  2008-08       Impact factor: 5.186

9.  Characterisation of a metallic foam-cement composite under selected loading conditions.

Authors:  Gianluca Tozzi; Qing-Hang Zhang; Colin Lupton; Jie Tong; Teodolito Guillen; Arne Ohrndorf; Hans-Jurgen Christ
Journal:  J Mater Sci Mater Med       Date:  2013-07-12       Impact factor: 3.896

10.  Increased risk of revision of acetabular cups coated with hydroxyapatite.

Authors:  Stergios Lazarinis; Johan Kärrholm; Nils P Hailer
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.